Hiroto Nishizawa
Juntendo University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Hiroto Nishizawa.
American Journal of Physiology-cell Physiology | 2008
Nagomi Kurebayashi; Hiroto Nishizawa; Yuji Nakazato; Hidetake Kurihara; Satoshi Matsushita; Hiroyuki Daida; Yasuo Ogawa
To investigate how intercellular coupling can be changed during Ca2+ overloading of ventricular muscle, we studied Ca2+ signals in individual cells and the histochemistry of the major gap junction channel, connexin43 (Cx43), using multicellular preparations. Papillary muscles were obtained from guinea pig ventricles and loaded with rhod-2. Sequential Ca2+ images of surface cells were obtained with a confocal microscope. In intact muscles, all cells showed simultaneous Ca2+ transients in response to field stimulation over a field of view of 0.3 x 0.3 mm2. In severely Ca2+-overloaded muscles, obtained by high-frequency stimulation in nonflowing Krebs solution, cells became less responsive to stimulation. Furthermore, nonsimultaneous but serial onsets of Ca2+ transients were often detected, suggesting a propagation delay of action potentials. The time lag of the onset between two aligned cells was sometimes as long as 100 ms. Similar lags were also observed in muscles with gap junction channels inhibited by heptanol. To investigate whether the phosphorylation state of Cx43 is affected in Ca2+-overloaded muscles, the distributions of phosphorylated and nonphosphorylated Cx43 were determined using specific antibodies. Most of the Cx43 was phosphorylated in the nonoverloaded muscles, whereas nonphosphorylated Cx43 was significantly elevated in severely Ca2+-overloaded muscles. Our results suggest that the propagation delay of action potential within a small area, a few square millimeters, can be a cause of abnormal conduction and a microreentry in Ca2+-overloaded heart. Inactivation of Na+ channels and inhibition of gap junctional communication may underlie the cell-to-cell propagation delay.
PLOS ONE | 2012
Takeshi Suzuki; Takao Shioya; Takashi Murayama; Masami Sugihara; Fuminori Odagiri; Yuji Nakazato; Hiroto Nishizawa; Akihito Chugun; Takashi Sakurai; Hiroyuki Daida; Sachio Morimoto; Nagomi Kurebayashi
Background Patients with inherited dilated cardiomyopathy (DCM) frequently die with severe heart failure (HF) or die suddenly with arrhythmias, although these symptoms are not always observed at birth. It remains unclear how and when HF and arrhythmogenic changes develop in these DCM mutation carriers. In order to address this issue, properties of the myocardium and underlying gene expressions were studied using a knock-in mouse model of human inherited DCM caused by a deletion mutation ΔK210 in cardiac troponinT. Methodology/Principal Findings By 1 month, DCM mice had already enlarged hearts, but showed no symptoms of HF and a much lower mortality than at 2 months or later. At around 2 months, some would die suddenly with no clear symptoms of HF, whereas at 3 months, many of the survivors showed evident symptoms of HF. In isolated left ventricular myocardium (LV) from 2 month-mice, spontaneous activity frequently occurred and action potential duration (APD) was prolonged. Transient outward (Ito) and ultrarapid delayed rectifier K+ (IKur) currents were significantly reduced in DCM myocytes. Correspondingly, down-regulation of Kv4.2, Kv1.5 and KChIP2 was evident in mRNA and protein levels. In LVs at 3-months, more frequent spontaneous activity, greater prolongation of APD and further down-regulation in above K+ channels were observed. At 1 month, in contrast, infrequent spontaneous activity and down-regulation of Kv4.2, but not Kv1.5 or KChIP2, were observed. Conclusions/Significance Our results suggest that at least three steps of electrical remodeling occur in the hearts of DCM model mice, and that the combined down-regulation of Kv4.2, Kv1.5 and KChIP2 prior to the onset of HF may play an important role in the premature sudden death in this DCM model. DCM mice at 1 month or before, on the contrary, are associated with low risk of death in spite of inborn disorder and enlarged heart.
PLOS ONE | 2009
Hiroto Nishizawa; Takeshi Suzuki; Takao Shioya; Yuji Nakazato; Hiroyuki Daida; Nagomi Kurebayashi
Background Abnormal Ca2+ transients are often observed in heart muscles under a variety of pathophysiological conditions including ventricular tachycardia. To clarify whether these abnormal Ca2+ transients can be attributed to abnormal action potential generation or abnormal Ca2+ handling/excitation-contraction (EC) coupling, we developed a procedure to determine Ca2+ and action potential signals at the cellular level in isolated heart tissues. Methodology/Principal Findings After loading ventricular papillary muscle with rhod-2 and di-4-ANEPPS, mono-wavelength fluorescence images from rhod-2 and ratiometric images of two wavelengths of emission from di-4-ANEPPS were sequentially obtained. To mimic the ventricular tachycardia, the ventricular muscles were field-stimulated in non-flowing Krebs solution which elicited abnormal Ca2+ transients. For the failed and alternating Ca2+ transient generation, there were two types of causes, i.e., failed or abnormal action potential generation and abnormal EC coupling. In cells showing delayed initiation of Ca2+ transients with field stimulation, action potential onset was delayed and the rate of rise was slower than in healthy cells. Similar delayed onset was also observed in the presence of heptanol, an inhibitor of gap junction channels but having a non-specific channel blocking effect. A Na+ channel blocker, on the other hand, reduced the rate of rise of the action potentials but did not result in desynchronization of the action potentials. The delayed onset of action potentials can be explained primarily by impaired gap junctions and partly by Na+ channel inactivation. Conclusions/Significance Our results indicate that there are multiple patterns for the causes of abnormal Ca2+ signals and that our methods are useful for investigating the physiology and pathophysiology of heart muscle.
Europace | 2005
S. Akitoshi; Yuji Nakazato; Hiroto Nishizawa; H. Tuchiya; Yasunobu Kawano; Takashi Tokano; Masayuki Yasuda; Hiroyuki Daida
Biophysical Journal | 2010
Takeshi Suzuki; Masami Sugihara; Hiroto Nishizawa; Akihito Chugun; Takashi Murayama; Takashi Sakurai; Hiroyuki Daida; Sachio Morimoto; Yuji Nakazato; Nagomi Kurebayashi
Biophysical Journal | 2010
Nagomi Kurebayashi; Hiroto Nishizawa; Takeshi Suzuki; Takao Shioya; Yuji Nakazato
Proceedings of Annual Meeting of the Physiological Society of Japan Proceedings of Annual Meeting of the Physiological Society of Japan | 2008
Nagomi Kurebayashi; Takeshi Suzuki; Hiroto Nishizawa; Yuji Nakazato; Takao Shioya
Archive | 2008
Satoshi Matsushita; Hiroyuki Daida; Yasuo Ogawa; Nagomi Kurebayashi; Hiroto Nishizawa; Yuji Nakazato; Hidetake Kurihara
Journal of Molecular and Cellular Cardiology | 2008
Takeshi Suzuki; Hiroto Nishizawa; Yuji Nakazato; Takashi Murayama; Takao Shioya; Takashi Sakurai; Hiroyuki Daida; Sachio Morimoto; Nagomi Kurebayashi
Japanese Circulation Journal-english Edition | 2008
Masataka Sumiyoshi; Haruhiko Abe; Ritsuko Kohno; Kaoru Komatsu; Hiroto Nishizawa; Hidemori Hayashi; Takeshi Suzuki; Hiroto Tsuchiya; Gaku Sekita; Yasunobu Kawano; Takashi Tokano; Yuji Nakazato; Hiroyuki Daida